Abstract
The author engages in further debate between numerous signatories of a letter who disputes that the author has put forward that the anticipated benefits of a personalised program for cancer prevention and screening are unwarranted. In the event that a cancer screening program is an effective means of mortality reduction, then the best strategy is universality. The benefit of a novel intervention should be evaluated prior to its introduction.
This is a preview of subscription content, log in via an institution to check access.
References
Narod SA, Sopik V (2018) Is invasion a necessary step for metastases in breast cancer? Breast Cancer Res Treat 169:9–23. https://www.ncbi.nlm.nih.gov/pubmed/29353366
Sopik V, Narod SA (2018) The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Res Treat 170:647–656. https://www.ncbi.nlm.nih.gov/pubmed/29693227
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Narod, S.A. Author response to “a response to ‘personalised medicine and population health: breast and ovarian cancer’”. Hum Genet 138, 291–292 (2019). https://doi.org/10.1007/s00439-019-01981-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-019-01981-2